299 assets in Alzheimer Disease

Therapeutic assets addressing Alzheimer Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
AV-1980R Alzheimer Disease	Institute for Molecular Medicine	P1	C (37)
Bnh-015B Alzheimer Disease	BnH Research	P1	C (37)
cm383 Alzheimer Disease	Keymed Biosciences Co.Ltd	P1	C (37)
Ddn-A-0101 Alzheimer Disease	Pharmacobio	P1	C (37)
Donepezil Dihydroxynaphthalate For Alzheimer Disease	Shanghai Synergy Pharmaceutical Sciences Co., Ltd.	P1	C (37)
Dspe-Dota-Gd Liposomal Alzheimer Disease	Alzeca Biosciences, Inc.	P1	C (37)
Fluoroethylnormemantine Alzheimer Disease	ReST Therapeutics	P1	C (37)
Huc-Msc-Sev-001 Nasal Drops Alzheimer Disease	Xuanwu Hospital, Beijing	P1	C (37)
ion269 Alzheimer Disease	Ionis Pharmaceuticals, Inc.	P1	C (37)
j4 Alzheimer Disease	Academia Sinica, Taiwan	P1	C (37)
KS101 Alzheimer Disease	Klotho Sciences Australia Pty Ltd.	P1	C (37)
ly3439539 Alzheimer Disease	Eli Lilly and Company	P1	C (37)
ly3954068 Alzheimer Disease	Eli Lilly and Company	P1	C (37)
ly4006895 Alzheimer Disease	Eli Lilly and Company	P1	C (37)
nio752 Alzheimer Disease	University College, London	P1	C (37)
Olx-07010 Active Alzheimer Disease	Oligomerix, Inc	P1	C (37)
Galcanezumab Alzheimer Disease	Xuanwu Hospital, Beijing	Early P1	C (34)
Low Thc Alzheimer Disease	Mclean Hospital	Early P1	C (34)
NOS Alzheimer Disease	University of Pennsylvania	Early P1	C (34)
Teonanacatl Alzheimer Disease	Johns Hopkins University	Early P1	C (34)
L. Lactis Ckdb001 Alzheimer Disease	CKD Bio Corporation	N/A	D (30)
PE 2I Alzheimer Disease	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
SDM-8 Alzheimer Disease	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
Aβ 1-40 Alzheimer Disease	University Hospital, Tours	N/A	D (28)
Blood, Whole Alzheimer Disease	Centre Hospitalier Universitaire, Amiens	N/A	D (28)
Hydrogen Alzheimer Disease	Wonju Severance Christian Hospital	N/A	D (28)
8m2d Alzheimer Disease	Cenna Biosciences Inc.	P1	NR ()
ak152 Alzheimer Disease	Akeso	P1	NR ()
CGB3002 Alzheimer Disease	ChainGen Biopharma Ltd	P1	NR ()
DUVAX Alzheimer Disease	Nuravax, Inc.	P1	NR ()
Gut-X-001 Alzheimer Disease	Beijing Tiantan Hospital	P1/2	NR ()
ht-4253 Alzheimer Disease	Halia Therapeutics, Inc.	P2	NR ()
Iti-1284 Alzheimer Disease	Intra-Cellular Therapies, Inc.	P2	NR ()
Lithium Orotate Alzheimer Disease	Johns Hopkins University	P1/2	NR ()
ly03017 Alzheimer Disease	Luye Pharma Group Ltd.	P1	NR ()
Mib-626 Alzheimer Disease	Brigham and Women's Hospital	P1/2	NR ()
ml-007c-ma Alzheimer Disease	MapLight Therapeutics	P2	NR ()
Neural Stem Cell-Derived Exosomes Alzheimer Disease	Shanghai Mental Health Center	P1	NR ()
Neuroepo Alzheimer Disease	University of Saskatchewan	P2	NR ()
Nicotinamide Ribonucleoside Alzheimer Disease	Mclean Hospital	Early P1	NR ()
qlh2405 Alzheimer Disease	Qilu Pharmaceutical Co., Ltd.	P1	NR ()
tau2 Alzheimer Disease	Paul S. Aisen	P2	NR ()
vy7523 Alzheimer Disease	Voyager Therapeutics	P1/2	NR ()

Showing 251 to 299 of 299 assets

PreviousPage 6 of 6Next